Benzinga | Jul 30, 2020 04:03PM EDT

Seattle Genetics Q2 EPS $(0.12) Beats $(0.63) Estimate, Sales $278.00M Beat $256.06M Estimate

Seattle Genetics (NASDAQ:SGEN) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.63) by 80.95 percent. This is a 75.51 percent increase over losses of $(0.49) per share from the same period last year. The company reported quarterly sales of $278.00 million which beat the analyst consensus estimate of $256.06 million by 8.57 percent. This is a 27.26 percent increase over sales of $218.45 million the same period last year.